Jannes Govaerts

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer

B. Neyns, Z. Berneman, J. Borst, 2022, Oncoimmunology.

The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology

M. Mazzone, J. V. Van Ginderachter, Abhishek D Garg, 2022, Cells.

A lymph node-to-tumour PDL1+macrophage circuit antagonizes dendritic cell immunotherapy

Susan M. Schlenner, O. Kepp, G. Kroemer, 2023, bioRxiv.

Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer

D. Lambrechts, F. De Smet, A. Liston, 2023, Science Translational Medicine.

Trial watch: chemotherapy-induced immunogenic cell death in oncology

P. Vandenabeele, L. Zitvogel, O. Kepp, 2023, Oncoimmunology.

Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer

F. Finotello, A. Wolthuis, X. Sagaert, 2023, Cell discovery.

Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells

Susan M. Schlenner, O. Kepp, Liwei Zhao, 2024, Cell reports. Medicine.